Health Invest Partners Ab Autolus Therapeutics PLC Transaction History
Health Invest Partners Ab
- $215 Million
- Q1 2025
A detailed history of Health Invest Partners Ab transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Health Invest Partners Ab holds 479,644 shares of AUTL stock, worth $628,333. This represents 0.34% of its overall portfolio holdings.
Number of Shares
479,644
Previous 479,644
-0.0%
Holding current value
$628,333
Previous $1.13 Million
34.07%
% of portfolio
0.34%
Previous 0.54%
Shares
4 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$35.5 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$26.8 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$23.4 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$21.8 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$14.4 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $119M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...